Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

07. January 2021 - 0:00 (CEST)

Epigenomics AG issues mandatory convertible bond in the amount of up to EUR 5.5 million

Read more

03. November 2020 - 0:00 (CEST)

Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned

Read more

16. October 2020 - 0:00 (CEST)

Epigenomics AG: U.S. Centers for Medicare & Medicaid Services publish negative proposed NCD for Epi proColon

Read more

Press releases

27. January 2021

Epigenomics AG: Dr. Garces transitions to Company Advisor

Read more

21. January 2021

Epigenomics AG Plans to Challenge NCD Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening

Read more

12. November 2020

Epigenomics AG reports financial results for the first nine months of 2020

Read more